Pirates' Paul Skenes sets MLB record with dominant shutout performance
Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees stock surge to highest level since 2015 amid optimism about its strategy and pipeline.
Under Armour's revenue falls, missing earnings estimates, as it focuses on brand repositioning and cost-cutting amid economic challenges.
Pirates' Paul Skenes sets MLB record with dominant shutout performance
Gilead Sciences reports strong Q2 2025 results, raises full-year guidance, and sees stock surge to highest level since 2015 amid optimism about its strategy and pipeline.
Under Armour's revenue falls, missing earnings estimates, as it focuses on brand repositioning and cost-cutting amid economic challenges.